The collaboration here at the University of Missouri to bring this product from MURR, through the research process, and into clinical application is an extraordinary example of our commitment to precision medicine. In 2021, MURR entered into an exclusive multi-year agreement with Advanced Accelerator Applications International, SA (ADACAP), a Novartis company, to provide Lu-177, the key ingredient in Pluvicto and Lutathera, a similar infusion treatment for neuroendocrine tumors
With a range of alternatives available, from lifestyle changes to emerging therapies, there are multiple paths to achieving sustainable weight loss without unnecessary risk
Plan your more intense workouts for days 3-7 after your injection, when side effects are typically at their lowest
W staej ofercie znajduj si produkty w kolorze czarnym, ale istnieje moliwo produkcji w wybranym kolorze na yczenie klienta